2 days Buy Gilead Sciences (GILD) Stock at 52-Week Highs? Zacks

   X     

4 days Gilead Sciences, Inc. (GILD) Hits Fresh High: Is There Still Room to Run? Zacks

   X     

5 days Gilead Sciences, Inc. (GILD) TD Cowen 45th Annual Healthcare Conference (Transcript) Seeking Alpha

   X     

1 week Wall Street Bulls Look Optimistic About Gilead (GILD): Should You Buy? Zacks

   X     

2 weeks Why Gilead Sciences Remains A Buy After A 40% Rally Seeking Alpha

   X     

2 weeks The Zacks Analyst Blog Highlights Charles Schwab, Gilead, Medtronic, Cooper-Standard and Rave Restaurant Zacks

   X     

2 weeks Zacks.com featured highlights Gilead Sciences, Exelixis, Synchrony Financial and Molson Coors Zacks

   X     

2 weeks Morgan Stanley sees FDA approval of GILD’s Lenacapavir Investing.com

   X     

2 weeks Market Update: BKNG, THRM, DHI, GILD, WMT, XYZ Yahoo Finance

   X     

3 weeks Biotech Stock Roundup: MRNA’s Q4 Results, GILD’s Update & Other News Zacks

   X     

3 weeks Calls of the Day: Gilead Sciences and Merck YouTube

   X     

3 weeks Deutsche Bank upgrades Gilead on its HIV treatment franchise Investing.com

   X     

3 weeks Gilead Stock Rises 8% Post Q4 Earnings: Should You Buy or Sell? Zacks

   X     

3 weeks Biotech Stock Roundup: GILD Up on Q4 Results, BIIB, BMY Down on 2025 Guidance Zacks

   X     

4 weeks Gilead Sciences, Inc. 2024 Q4 – Results – Earnings Call Presentation Seeking Alpha

   X     

4 weeks Gilead Sciences, Inc. (GILD) Q4 2024 Earnings Call Transcript Seeking Alpha

   X     

4 weeks Gilead (GILD) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates Zacks

   X     

4 weeks Gilead provides upbeat 2025 forecast, shares rise 4% Investing.com

   X     

4 weeks Gilead Sciences (GILD) Tops Q4 Earnings and Revenue Estimates Zacks

   X     

4 weeks Gilead provides upbeat 2025 forecast, shares rise nearly 5% Investing.com

   X     

4 weeks Gilead Hits Buy Zone After Obliterating Fourth-Quarter Expectations Investor's Business Daily

   X     

4 weeks Gilead Beats Earnings Estimates on Strong HIV Sales. The Stock Is Rising. Yahoo Finance

   X     

4 weeks Gilead Sciences: Diversification Strategy Not Derisked Enough Yet Seeking Alpha

   X     

4 weeks The Zacks Analyst Blog Uber, Comcast, Gilead Sciences and Onfolio Holdings Zacks

   X     

1 month Top Analyst Reports for Uber, Comcast & Gilead Zacks

   X     

1 month Gilead Sciences to Report Q4 Earnings: Is a Beat in the Cards? Zacks

   X     

1 month Final Trade: UBER, MP, MGNI, GILD YouTube

   X     

1 month Gilead Sciences (GILD) Surpasses Market Returns: Some Facts Worth Knowing Zacks

   X     

1 month Gilead Sciences (GILD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release Zacks

   X     

1 month Gilead Sciences (GILD) Rises As Market Takes a Dip: Key Facts Zacks

   X     

1 month Gilead: Strong Sales Growth Remains With Veklury And Beyond Seeking Alpha

   X     

1 month Will Gilead (GILD) Beat Estimates Again in Its Next Earnings Report? Zacks

   X     

1 month Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock Zacks

   X     

1 month Gilead Sciences (GILD) Stock Dips While Market Gains: Key Facts Zacks

   X     

1 month Is It Worth Investing in Gilead (GILD) Based on Wall Street’s Bullish Views? Zacks

   X     

2 months GILD vs. ALNY: Which Stock Is the Better Value Option? Zacks

   X     

2 months Why Gilead Sciences (GILD) Outpaced the Stock Market Today Zacks

   X     

2 months Can Gilead Sciences Sustain Its Growth Momentum in 2025? Zacks

   X     

2 months The Zacks Analyst Blog Salesforce, Shell and Gilead Sciences Zacks

   X     

2 months Top Stock Reports for Salesforce, Shell, Gilead Sciences & Others Zacks

   X     

2 months Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing Zacks

   X     

2 months Gilead Sciences, US government settle patent case over HIV prevention drugs Investing.com

   X     

2 months Final Trade: ANF, GILD YouTube

   X     

2 months Gilead Sciences, Inc. (GILD) JPMorgan Annual Healthcare Conference – (Transcript) Seeking Alpha

   X     

2 months Drugmakers Just Hiked Prices for Over 500 Medicines Money.com

   X     

2 months Gilead CEO on funding for new HIV prevention medicine YouTube

   X     

2 months Gilead CEO Daniel O’Day on new HIV prevention medicine: It’s going to change the face of HIV YouTube

   X     

2 months Gilead, LEO Pharma partner to develop programs for inflammatory diseases Investing.com

   X     

2 months Morgan Stanley upgrades Gilead on HIV treatment growth Investing.com

   X     

2 months Gilead Sciences (GILD) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks

   X